PBAC Update

The November 2021 Pharmaceutical Benefits Advisory Committee (PBAC) meeting was held on 3-5 November 2021. At this meeting the PBAC considered whether amendments to Pharmaceutical Benefits Scheme (PBS) listings of antipsychotic medications are appropriate in light of Recommendation 65 of the Royal Commission into Aged Care Quality and Safety’s Final Report.

The PBAC did not recommend making amendments to the PBS listings of antipsychotic medications. The PBAC will continue to monitor the use of antipsychotics in aged care. Further information about the November 2021 meeting outcomes is now available here.